ICICI Pru Life (ICICIPRULI)
Slow GrowerFairStock Score: 45/100 — MIXED
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹509.15 |
| Market Cap | ₹73,814.15 Cr |
| P/E Ratio | 43.85 |
| ROCE | 11.94% |
| ROE | 12.58% |
| Dividend Yield | 0.32% |
| Profit Growth | 61.4% |
| Debt/Equity | 0.19 |
| Sales Growth | -83.1% |
| Free Cash Flow | ₹2,216 Cr |
| Promoter Holding | 72.88% |
| 52-Week Range | ₹456 — ₹706.8 |
| Sector | Insurance |
| Book Value | ₹94.06 |
Strengths
- High promoter holding of 72.88% promotes ownership alignment and stability.
- Low leverage with debt/equity of 0.19 gives financial resilience.
- Positive free cash flow of ₹2,216 Cr signals genuine cash-generating ability.
- Profit growth of 40.59% and Piotroski F-Score of 7/9 point to improving fundamentals.
- Book value of ₹82.36 offers a tangible equity base, though current price is far above it.
Concerns
- Valuation is stretched: P/E of 69.26, P/B of 6.50, and EV/EBITDA of 188.25 leave little margin of safety.
- Top line is stagnant: sales growth is -2.21% and the 5-year revenue CAGR is -0.07%.
- Graham Number of ₹132.68 is far below the market price of ₹535.05, indicating a deep valuation gap.
- Dividend yield of just 0.13% offers negligible cash return while waiting for growth.
AI Analysis
Looking at ICICI Pru Life, I see a business with qualities to admire and a price that tests my discipline. The promoter holding of 72.88% aligns majority and minority interests, and the balance sheet is conservatively funded with debt/equity of just 0.19. Free cash flow of ₹2,216 crore is a genuine positive, and the Piotroski score of 7/9 suggests the company has become financially and operationally sound. Profit growth of 40.59% is excellent, yet it sits beside a worry: sales declined by 2.21%, while the five-year revenue CAGR is -0.07%. As Graham would say, one year of reported profit cannot be the whole story when the top line is drifting sideways. Return on equity of 11.47% and ROCE of 11.94% are respectable but unspectacular; for a stock at 6.50 times book value, I need more. The P/E of 69.26 and PEG ratio of 3.25 tell me Mr. Market is paying a steep price for a life insurer with flat revenue. The Graham Number of ₹132.68 versus the current ₹535.05 leaves no margin of safety whatsoever. Even acknowledging that the Altman Z-score was not designed for insurers, a score of 0.47 does not reassure me. In short, this is a stable operator with improving profitability, but quality is not the same as a bargain. At this price, the market is betting on a growth revival and sustained margin expansion. I require those to show up in the actual numbers before I can deploy capital. Patience protects my downside; price decides my entry.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer